MX9400801A - Agentes colinergicos de oxima de tetrahidropiridinna o-substituidos estabilizados con almidon. - Google Patents

Agentes colinergicos de oxima de tetrahidropiridinna o-substituidos estabilizados con almidon.

Info

Publication number
MX9400801A
MX9400801A MX9400801A MX9400801A MX9400801A MX 9400801 A MX9400801 A MX 9400801A MX 9400801 A MX9400801 A MX 9400801A MX 9400801 A MX9400801 A MX 9400801A MX 9400801 A MX9400801 A MX 9400801A
Authority
MX
Mexico
Prior art keywords
starch
substituted
tetrahidropiridinna
collergic
oxym
Prior art date
Application number
MX9400801A
Other languages
English (en)
Inventor
Galen W Radebaugh
Mahdi B Fawzi
Hua-Pin Huang
Scott C Wootton
Thomas N Julian
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MX9400801A publication Critical patent/MX9400801A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Las composiciones sólidas de ciertos compuestos colinérgicos se estabilizan en almidón. Especialmente composiciones de almidón de maíz combinados o mezclados con el éter de oxima de O-substituida-1,2,5,6-tetrahidro-3-piridina, CI-979 HC1, un activador cognoscitivo, se ha encontrado que son estables en un medio ambiente calentados hasta 60°C durante más de 17 días de manera tal que no se detectan pérdidas mediante el análisis de HPLC. Una formulación farmacéutica perorar sólida para tratamiento de trastornos cognoscitivos se basa en la composición bicomponente del ingrediente activo y el estabilizador, usando cantidades apropiadas de otros excipientes o compuestos conocidos en el ramo de formulación.
MX9400801A 1993-02-01 1994-01-31 Agentes colinergicos de oxima de tetrahidropiridinna o-substituidos estabilizados con almidon. MX9400801A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/012,108 US5424301A (en) 1993-02-01 1993-02-01 Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents

Publications (1)

Publication Number Publication Date
MX9400801A true MX9400801A (es) 1994-08-31

Family

ID=21753427

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9400801A MX9400801A (es) 1993-02-01 1994-01-31 Agentes colinergicos de oxima de tetrahidropiridinna o-substituidos estabilizados con almidon.

Country Status (6)

Country Link
US (1) US5424301A (es)
EP (1) EP0681472A1 (es)
JP (1) JPH08506120A (es)
CA (1) CA2150373A1 (es)
MX (1) MX9400801A (es)
WO (1) WO1994017802A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA937382B (en) * 1992-10-06 1994-04-29 Warner Lambert Co Novel composition for peroral therapy of cognitionimpairment and a process therefor
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7678363B2 (en) * 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3523871A (en) * 1966-07-20 1970-08-11 Eisai Co Ltd Stabilization of catalase
US3446894A (en) * 1966-09-15 1969-05-27 Hoffmann La Roche Stabilization of vitamin c tablets
US3533871A (en) * 1968-04-10 1970-10-13 Armstrong Cork Co Nonwoven tufted fabric by crimping
CH642990A5 (de) * 1978-07-24 1984-05-15 Parke Davis & Co Verfahren zum faerben von gelatine fuer kapseln mit hilfe eines gegen den abbau durch licht oder oxidation stabilisierten natuerlichen farbstoffes.
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
JPS61165322A (ja) * 1985-01-14 1986-07-26 Microbial Chem Res Found スパガリン類の注射用凍結乾燥製剤
IL81610A (en) * 1986-02-27 1990-12-23 Roussel Uclaf Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them
IL83275A (en) * 1986-09-08 1994-02-27 Novo Nordisk As Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them
US4786648A (en) * 1986-12-08 1988-11-22 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
US4812445A (en) * 1987-02-06 1989-03-14 National Starch And Chemical Corporation Starch based encapsulation process
IT1203971B (it) * 1987-04-24 1989-02-23 Roussel Maestretti Spa Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti
IT1222529B (it) * 1987-08-21 1990-09-05 Roussel Maestretti Spa Derivati dell' ossima della 1,2,5,6-tetraidropirdin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
JPH02268681A (ja) * 1989-04-07 1990-11-02 Green Cross Corp:The ウロキナーゼ前駆体の安定化方法及び乾燥製剤

Also Published As

Publication number Publication date
WO1994017802A1 (en) 1994-08-18
CA2150373A1 (en) 1994-08-18
EP0681472A1 (en) 1995-11-15
JPH08506120A (ja) 1996-07-02
US5424301A (en) 1995-06-13

Similar Documents

Publication Publication Date Title
MX9400801A (es) Agentes colinergicos de oxima de tetrahidropiridinna o-substituidos estabilizados con almidon.
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
BR0014383A (pt) Composições de liberação controlada compreendendo nimesulida
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
ATE431149T1 (de) Analoge der barbitursäure als therapeutische wirkstoffe
DE69418468D1 (de) Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
IT1206341B (it) Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
MX9400800A (es) Un complejo de estabilizacion neutro para ci-979 hci, un activador de la cognicion.
NO941276D0 (no) Lipofile, oligosakkaride antibiotikasaltpreparater
BR0111678A (pt) Composições medicinais contendo derivados de propenona
DE3583916D1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
FI955403A0 (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
DK1147105T3 (da) Optisk aktivt pyridyl-4H-1,2,4-oxadiazinderivat og anvendelse af dette til behandling af karsygdomme
ATE363909T1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
EA200500671A1 (ru) Фармацевтический состав оланзапина
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
ES2057053T3 (es) Compuestos benzoheterociclicos.
ES2083490T3 (es) 3,5-diyodo-l-tironina para la supresion de tsh y el tratamiento del bocio.
SE0203817D0 (sv) New composition

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees